The approval is supported by data from a phase 3 study that assessed the efficacy and safety of Botox in patients aged 5 to 17 years with urinary incontinence due to NDO and using clean intermittent catheterization.
Children with versus those without AKI have lower scores on tests of short-term memory during DKA
The alert was based on data from three 20-week double-blind, placebo-controlled studies each with 34-week extensions.
The use of NSAIDs after 20 weeks of pregnancy may lead to low levels of amniotic fluid surrounding the baby resulting in kidney complications.
Length of stay, costs, mortality risk greater than for children hospitalized with other chronic illnesses.
Compared with children starting dialysis in 1995, those starting dialysis after 2006 had a significant 26% decreased risk of dying from cardiovascular causes in adjusted analyses.
65% of couples using IVF who selected testing had at least one live birth of an unaffected child.
The FDA has approved Vesicare LS (solifenacin succinate; Astellas Pharma) oral suspension for the treatment of neurogenic detrusor overactivity (NDO) in pediatric patients 2 years of age and older.
Horizon Therapeutics announced the availability of Procysbi (cysteamine bitartrate) delayed-release oral granules in tear-open packets for the treatment of nephropathic cystinosis in patients aged 1 year and older.
But high average blood pressure on 24-hour test strongly predicts child’s cardiac, kidney disease risk.
